TGA Proposal to Ban Textured Breast Implants

The TGA has released a statement indicating a proposal to ban most textured implants on the market.

This has implications for past and current patients considering surgery.

Most importantly:

  • Past patients: with current media coverage we understand that many women will be concerned about their implant status. With a GP, A/Prof Magnusson will Bulk Bill a consultation to assess current status for current patients. A similar consultation can be undertaken by the SAH Breast Clinic especially for patients who had surgery elsewhere.
  • Current patients booked for surgery: all patients booked for surgery with textured implants need to be contacted. We will need to have smooth implant options available and another consultation if booked for textured implants.

Key Points:

A/Prof Magnusson is on the TGA Breast Implant Advisory Board and some of the research he has generated is implicated in the decisions the TGA is considering.

A/Prof Magnusson has been involved in research into breast implant associated-anaplastic large cell lymphoma (BIA-ALCL) for 5 years when little was known about this condition due to concerns that implants may be contributing to this rare condition. He has several publications on BIA-ALCL which have been used by regulators worldwide in assessing risk.

Our own data has helped shed light on the contributing causes of this problem and it appears that the body responding to bacteria around the implant is the underlying cause.

A/Prof Magnusson has always used specific antimicrobial steps at surgery for all breast implant patients since 2000. This has become known as the 14 point plan and is designed to help eliminate bacteria at the time of breast implant surgery.

One of his publications shows that these antimicrobial steps reduce the likelihood of ALCL further. With 6 colleagues, A/Prof Magnusson has examined 43000 breast implants who had surgery using these antibacterial steps with zero cases of ALCL.
A/Prof Magnusson has no personal cases of this condition at present.

The most common presentation of BIA-ALCL is swelling of one breast on average 8 years following the original surgery. A less common presentation is a mass or lump adjacent to an implant. These symptoms should not be overlooked and we are able to investigate these concerns to provide a definitive answer.

If you have any questions in regards to your breast implants, please don’t hesitate to contact the clinic.

To find out more information about our clinic operations during the COVID-19 outbreak, please click the button below: